DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation

Br J Haematol. 2021 Feb;192(3):e73-e77. doi: 10.1111/bjh.17248. Epub 2020 Nov 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / therapeutic use
  • Cytarabine / therapeutic use
  • Dexamethasone / therapeutic use
  • Doxorubicin / therapeutic use
  • Etoposide / therapeutic use
  • Female
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Multiple Myeloma / drug therapy
  • Multiple Myeloma / therapy*
  • Progression-Free Survival
  • Salvage Therapy*
  • Stem Cell Transplantation*
  • Thalidomide / therapeutic use
  • Transplantation, Autologous
  • Young Adult

Substances

  • DT PACE regimen
  • Cytarabine
  • Thalidomide
  • Etoposide
  • Dexamethasone
  • Doxorubicin
  • Cisplatin
  • Methylprednisolone

Supplementary concepts

  • ESAP protocol